1,139 results on '"Mufti, G."'
Search Results
52. Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London – 2005
53. Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
54. Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently
55. Differentially expressed genes in adult familial myelodysplastic syndromes
56. Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions
57. Peptide vaccination using combined adjuvants for synergistic activation of cellular immunity (CASAC) promotes potent WT1-specific immune responses in an in vivo mouse model: 38
58. Autoimmune haemolytic anaemia after allogeneic haematopoietic stem cell transplantation: analysis of 555 transplant patients at Kingʼs College Hospital: 37
59. Eculizumab in paroxysmal nocturnal haemoglobinuria (PNH): a report of all 153 patients treated in the UK: 8
60. Loevinger's measures of rule quality for assessing cluster stability
61. A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease (IFD) in adult haemato-oncology patients undergoing HSCT or high dose chemotherapy - results of the Kingʼs Prospective Aspergillosis Study (NCT00816088): 5
62. Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors
63. Survivorship following bone marrow transplant: a pilot study exploring responses to a life-coaching intervention: N1308
64. Retrospective analysis of 5-azacitidine as induction therapy prior to haematopoietic stem cell transplantation: P1172
65. Cytokine profile of patients with invasive aspergillosis: initial results from the first 100 patients recruited into the aspergillosis study; Great Britain: P1054
66. Video-assisted thoracoscopic biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high-dose chemotherapy: P775
67. Video-assisted thoracoscopic (VATS) biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high dose chemotherapy: 35
68. Separation of cell cycle and growth cycle programmes in primary human T cells: 42
69. JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis: authorsʼ reply
70. The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis
71. Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia
72. Transplant results in adults with Fanconi anaemia
73. Epigenetic code of primary human T cells during the first cell cycle: 216
74. Drug rash with eosinophilia and systemic symptoms and graft-versus-host disease developing sequentially in a patient
75. NK Cell-Mediated Immunologic Responses Against Myeloma by B7-1(CD80)/IL-2 Immune Gene Therapy: B446
76. Dasatinib and Dexamethasone Combination Therapy Targets Myeloma and the Tumor Microenvironment: B234
77. Seasonal variation in emergency referrals to a Surgical Assessment Unit
78. In vitro immune modulation by antibodies coupled to tumour cells
79. Benign polyps with prostatic-type epithelium of the urethra and the urinary bladder
80. Perineal Ileal conduit—Cutaneous fistula
81. Mixed donor chimaerism in recipient fingernails following reduced-intensity conditioning haematopoietic SCT
82. A review of 100 consecutive cases of myelodysplastic syndrome with skin disorders: O-13
83. Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease
84. The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow
85. Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia
86. Outcomes of MDS patients with chromosome 7 abnormalities treated with 5-azacytidine: 157
87. Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases maybe more informative
88. Reduced-intensity conditioned allogeneic haematopoietic transplantation in an adult with Langerhans’ cell histiocytosis and thrombocytopenia with absent radii
89. Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease
90. Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
91. An unusual case of bellini duct carcinoma
92. Interstitial cystitis in men
93. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation
94. JAK V617F missense mutation is absent in pancreatic cancer
95. Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia
96. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges
97. Complete response of deep neutrophilic dermatosis associated with myelodysplastic syndrome to 5-azacytidine
98. Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation
99. Systems biology analysis of the G0-G1 cell cycle transition of human primary T cells: 238
100. Use of quantitative PCR approaches to predict relapse and direct molecularly targeted therapy with arsenic trioxide (ATO) in acute promyelocytic leukaemia (APL): 116
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.